Ozempic, Wegovy users sue over rare, permanent blindness

More than 200 people who took the diabetes and weight-loss drugs Ozempic, Wegovy, or Mounjaro have filed federal lawsuits claiming these medications caused them to develop NAION, a rare condition that results in permanent vision loss. The drug manufacturers dispute these claims. The lawsuits are currently ongoing.

6 across the spectrum. Choose a side on the bar to jump to it.

National story. 6 articles from 6 sources. Updated Sep 26, 2026.

Selected headlines by outlet leaning

Left

2 sources

Same wire story as other sides. No original Left take here.

Ran by 5 outlets across the spectrum· Cleveland Plain Dealer, NJ.com / Star-Ledger
Cleveland Plain DealerLean Left· Sep 26, 2026

Ozempic, Wegovy users sue over rare, permanent blindness

NJ.com / Star-LedgerLean Left· Sep 26, 2026

Ozempic, Wegovy users sue over rare, permanent blindness

Center

2 sources

Same wire story as other sides. No original Center take here.

Ran by 5 outlets across the spectrum· The Oregonian, MLive
The OregonianCenter· Sep 26, 2026

Ozempic, Wegovy users sue over rare, permanent blindness

MLiveCenter· Sep 26, 2026

Ozempic, Wegovy users sue over rare, permanent blindness

Right

2 sources
AL.comLean Right· Sep 26, 2026· ran in 5 outlets

Ozempic, Wegovy users sue over rare, permanent blindness

End Time HeadlinesLean Right· Sep 24, 2026

Ozempic and Wegovy face numerous lawsuits over rare ‘eye stroke’ linked to vision loss

The bigger story

This story is one of several related ones. Here's where it sits.